Back to News

TikaMobile Announces Business Intelligence CRM Solution for Market Access Teams to Increase Coverage and Pull-through Performance of Sales Teams

New York, NY, December 6, 2018 (Globe Newswire) — TikaMobile, the premier leader in cloud-based business intelligence and CRM software for the global life sciences industry, announces the latest advancement to its innovative analytics CRM platform – TikaMarketAccess. TikaMarketAccess provides teams with critical, real-time intelligence and visibility into formulary timelines and strategy planning for pull-through success through a single, easy-to-use app that is available on phones, tablets and through the web.

The app empowers payer teams to outperform competitors in the industry by forming and maintaining powerful relationships with payers, ultimately improving overall patient population coverage and access to innovative therapies.

“Stakeholders at all levels require access to transparent and relevant data to quickly adapt and maintain a position of strategic advantage," Manish Sharma, founder and CEO of TikaMobile, explains. "Made expressly for Market Access and Reimbursement teams, TikaMarketAccess is a powerful mobile application that provides vital actionable business intelligence, enabling Market Access teams to cultivate strong relationships with payers and communicate key formulary information to their sales reps in real-time.”

TikaMarketAccess provides Market Access teams with the ability to:

  • Manage contracts and pricing;
  • Create a  pipeline of payers;
  • Handle clinical requests and accepted response dates;
  • Analyze a comprehensive overview of competitor activity;
  • Gain insight into formulary plan coverage for different therapeutic groups;
  • Drill into specific plan details, including number of lives by plan or by state; and push real-time alerts to sales reps for formulary wins by location and physician.

With this new offering, Market Access teams now have the opportunity to overcome the legacy challenges in the industry – hunting around for disparate data, waiting days for information requests, relying on stale spreadsheets, etc. – by using technology that provides a single, easy-to-access source of real-time intelligence. TikaMobile provides its clients with the most innovative life sciences sales enablement technology that enables them to strategically and efficiently execute their product launches and sustained sales efforts.

If you have any questions regarding this new technology, please email rthomas@tikamobile.com.

About TikaMobile, Inc.

TikaMobile, Inc. is the premier leader in cloud-based business intelligence and CRM software for the global life sciences industry. By combining many disparate sales and marketing tools into a single easy-to-use application, while applying prescriptive, actionable analytics across the commercial organization, Tika is transforming and optimizing sales organizations for pharmaceutical and medical device companies. Tika is committed to innovation, product excellence, and customer success and works with organizations of all sizes. Headquartered in New York City, Tika has offices in the United States, Europe and India.

For more information, visit www.TikaMobile.com.

December 6, 2018

You might also like

June 14, 2025

Pharma’s 2025 Guide to HCP Digital Engagement: Proven Omnichannel and AI Strategies to Boost Provider Relationships

Table Of Content Introduction: Why HCP Digital Engagement Matters in 2025 The 2025 Playbook: 7 Proven Strategies The HCP Engagement Maturity Model HCP Engagement Program Checklist Final Thoughts:.

June 3, 2025

Understanding Medical Affairs CRM: Importance and Key Features

Table Of Content Defining Medical Affairs CRM: Core Concepts and Functions The Importance of Medical Affairs CRM in Life Sciences: Addressing Industry Needs The Evolution of Medical Affairs CRM:.

May 28, 2025

KOLs in Clinical Trials & Drug Development 2025 | Roles, Benefits, Strategies

1. Introduction: Why KOLs Matter in Modern Pharmaceutical R&D Clinical protocols are more demanding, patient populations more specialised, and regulatory expectations higher than ever. In this.